Caedryn Limited · 凯峻资本 · Hong Kong
Caedryn is a boutique advisory firm focused on SPAC sponsorship and reverse-merger transactions across the United States and Asia. We structure, execute — and commit our own capital alongside our partners.
Who We Are
Caedryn works at the intersection of two markets — U.S. capital markets, where SPACs and reverse mergers are executed, and Asia, where the next generation of listing candidates is built. We do one thing: help exceptional companies and sponsor teams navigate the route from private ownership to a public listing.
Unlike a conventional advisor, we are also a principal. In transactions we co-sponsor, our capital is at risk beside our partners'. That single fact disciplines every recommendation we make.
About the firmWhat We Do
Every mandate we take sits on the road between a private company and a public listing.
We form and capitalise special purpose acquisition companies together with operating partners and anchor investors — committing at-risk capital, sharing the promote, and carrying the vehicle from formation through de-SPAC.
Learn more 02For first-time and repeat sponsor teams, we act as an outsourced deal team: economics and promote structuring, SEC process management, extension strategy, target search and de-SPAC execution.
Learn more 03For companies and acquirers pursuing a listing through reverse takeover, we run shell diligence, structure and valuation negotiation, and regulatory navigation in the U.S. and Hong Kong.
Learn moreOur Data Centre
aedryn.com
Aedryn is Caedryn's data centre: a database of SPACs, de-SPAC deals, IPO filings and confirmed potential SPAC merger targets, with every figure traced to the SEC filing it came from. It powers our research and our transactions.
Aedryn is reserved for Caedryn's own research and projects. Clients and partners can request access.
Visit aedryn.com ↗ Request access
Counts as of 29 Oct 2026 · Source: SEC EDGAR
Research
In-depth reports on the SPAC and de-SPAC market, plus shorter insights on structuring, sponsor economics and reverse mergers. Every report is free with a company email.
Latest report · SEC Comment Letter Series, Vol. 1
Insights